Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 214

Results For "live"

3664 News Found

Global Hospitals Parel Mumbai completes 100 successful robotic surgeries
Medical Device | August 29, 2023

Global Hospitals Parel Mumbai completes 100 successful robotic surgeries

The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology


BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
Clinical Trials | August 29, 2023

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint

Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year


Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
People | August 29, 2023

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation

Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer


Apollo’s Apollo Connect program bets big on expanding access and elevating care
Digitisation | August 29, 2023

Apollo’s Apollo Connect program bets big on expanding access and elevating care

Aims to build the largest connected healthcare ecosystem in India


IBL Healthcare invests in KNISS Laboratories
Healthcare | August 28, 2023

IBL Healthcare invests in KNISS Laboratories

KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.


Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
Drug Approval | August 25, 2023

Lynparza plus abi/pred approved in Japan for treatment of prostate cancer

First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent


NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US
News | August 24, 2023

NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials


First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
Policy | August 24, 2023

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl

Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl


LEO Pharma to acquire Timber Pharmaceuticals
News | August 22, 2023

LEO Pharma to acquire Timber Pharmaceuticals

The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million


Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors
People | August 22, 2023

Former Bayer Pharma CEO Dieter Weinand joins Coya’s Board of Directors

Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business